Endolift laser as new non-surgical technique for nose remodeling.

BACKGROUND: In the last few years, facial rejuvenation has moved to less invasive or non-surgical techniques because their effects are visible immediately after the treatment, they have shorter recovery time and less pain and patients can go back to their normal life on the same day. Rhinoplasty is a cosmetic procedure that is very difficult to master. The main goal of rhinoplasty is anatomical preservation. One of novel technique for nose remodeling is laser therapy. In this study, the authors evaluate the efficacy of the endolift laser as a technique for nose remodeling. METHODS: A total of eight patients were enrolled and were submitted to endolift laser therapy. The outcomes were measured by photography, three blind board-certified dermatologists assessment, and patients satisfaction. RESULTS: Our results showed that endolift Laser as non-surgical nose remodeling technique is a safe and effective method. Clinical assessment of the physician showed a significant improvement at 6-months follow-up. Also, the patient satisfaction rate was higher in the enrolled participates. Also, no severe side effect was reported. CONCLUSION: The endolift laser technique is practicable, effective, and safe method for non-surgical nose job and has no major complication.

Successful treatment of nodular actinic reticuloid with tacrolimus ointment.

Actinic reticuloid (AR) is the severest clinical variant of chronic actinic dermatitis (CAD) and describes a persistent photoinduced skin disorder often associated with delayed-type hypersensitivity reactions. Histopathologically, AR resembles pseudolymphoma and may also show features of cutaneous lymphoma. In contrast to other UV-induced skin diseases, AR patients show persistent photosensitivity to UV radiation and visible light parallel to permanent changes of skin texture with infiltrated papules and thickened plaques. Therapeutically, CAD is a problematic condition. Daily application of sun protection has to be combined with local or systemic immunosuppression. However, various therapeutic approaches including systemic corticosteroids and other systemic immunosuppressive agents are limited by severe side effects. Tacrolimus, a Streptomyces-derived immunosuppressive macrolide antibiotic and inhibitor of calcineurin, has been proven successful in various inflammatory skin diseases including atopic eczema, allergic contact dermatitis and photodermatoses without undesired side effects. We present a case of severe recalcitrant and nodular chronic actinic dermatitis responding to topically applied tacrolimus (Protopic). To avoid further relapses we continued this therapy twice a day over a period of 2 years.